Haleon names Dawn Allen as CFO
Reuters
Published Apr 24, 2024 07:25
Updated Apr 24, 2024 16:32
(Reuters) -Consumer healthcare firm Haleon (LON:HLN) said on Wednesday that Dawn Allen has been appointed as its new chief financial officer, effective Nov. 1.
Allen, 55, currently CFO at British food ingredients maker Tate & Lyle (LON:TATE), replaces Tobias Hestler.
The change in CFO has taken place less than two months after Haleon unveiled its plan to buy back 500 million pounds ($622.2 million) of its shares this year, partly in its bid to reduce debt.
Hestler, 52, was CFO of GSK (LON:GSK)'s consumer wing from 2018 and held the top finance role since the formation of Haleon.
Haleon, which makes household brands such as Sensodyne toothpaste and Advil painkillers, was spun out of British drugmaker GSK in July 2022. It was formed in 2019 by merging GSK and Pfizer (NYSE:PFE)'s consumer healthcare businesses.
Both GSK and Pfizer have sold down their stake in Haleon since then, with the latter remaining as the London-listed firm's largest shareholder.
($1 = 0.8037 pounds)
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.